Tim Patrick is President and CEO of Windward Medical, Inc., an Atlanta-based company founded in August 2005 to focus on high potential emerging healthcare technologies.

Prior to founding Windward Medical, Inc., Tim was President, CEO and co-founder of Proxima Therapeutics, Inc., a company focused on the localized delivery of radiation for the treatment of cancer. Prior to co-founding Proxima, which was acquired by Cytyc Corporation in 2005, Tim was President of Gesco International, Inc., the leading manufacturer of peripherally inserted central venous (PICC) catheters. Gesco and its parent company, MedChem Products, Inc., were acquired by C.R. Bard, Inc. in 1995. Before serving as President of Gesco, Tim ran two high-growth divisions for McGaw Laboratories, serving most recently as President of Central Admixture Pharmacy Services and previously as Vice President and General Manager of the Alternate Site division. He also served in various sales and sales management roles at American Hospital Supply Corporation.

Tim, an inventor on several patents in the field of local radiation delivery, earned his Bachelor of Arts in Zoology from Miami University in Ohio. Tim has served on the boards of the Advanced Medical Technology Association (AdvaMed) and the Georgia Biomedical Partnership.